We are live on
!
Find out more
Beam Therapeutics
BEAM
BEAM
158 hedge funds and large institutions have $3.01B invested in Beam Therapeutics in 2020 Q4 according to their latest regulatory filings, with 80 funds opening new positions, 44 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,043% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 7
450% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 8
314% more capital invested
Capital invested by funds: $727M → $3.01B (+$2.29B)
86% more funds holding
Funds holding: 85 → 158 (+73)
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
6.65% more ownership
Funds ownership: 57.04% → 63.69% (+6.6%)
56% less call options, than puts
Call options by funds: $14.4M | Put options by funds: $32.8M
Holders
158
Holders Change
+73
Holders Change %
+85.88%
% of All Funds
2.8%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
80
Increased
44
Reduced
8
Closed
7
Calls
$14.4M
Puts
$32.8M
Net Calls
-$18.3M
Net Calls Change
-$18.3M
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$55.6M |
| 2 |
BlackRock
New York
|
+$45.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$44.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.9M |
| 5 |
Goldman Sachs
New York
|
+$26.1M |
